| MAY 2026 | APR 2026 | MAR 2026 | FEB 2026 | JAN 2026 | DEC 2025 | |
|---|---|---|---|---|---|---|
| Number of Holdings | 34 | 34 | 35 | 35 | 35 | 36 |
| Top 5 Company Holdings | 39.34% | 40.92% | 40.16% | 39.11% | 39.03% | 39.37% |
| Top 10 Company Holdings | 58.8% | 59.53% | 58.92% | 58.37% | 58.12% | 58.17% |
| Company with Highest Exposure | Sun Pharmaceutical Industries (13.35%) | Sun Pharmaceutical Industries (13.85%) | Sun Pharmaceutical Industries (13.92%) | Sun Pharmaceutical Industries (13.08%) | Sun Pharmaceutical Industries (12.67%) | Sun Pharmaceutical Industries (13.02%) |
| Number of Sectors | 1 | 1 | 1 | 1 | 1 | 1 |
| Top 3 Sector Holdings | 97.98% | 98.7% | 99.45% | 99.68% | 98.96% | 97.37% |
| Top 5 Sector Holdings | 97.98% | 98.7% | 99.45% | 99.68% | 98.96% | 97.37% |
| Sector with Highest Exposure | Healthcare (97.98%) | Healthcare (98.7%) | Healthcare (99.45%) | Healthcare (99.68%) | Healthcare (98.96%) | Healthcare (97.37%) |
(Scheme Rating)
Nippon India Pharma Fund-Growth
NAV as of Jun 17, 2026
535.25-0.12%
(Earn upto 0.85% Extra Returns with Direct Plan)
Investment Growth
Loading...
Nippon India Pharma Fund-Growth Fund Details
Investment Objective - The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
| Fund House | Nippon India Mutual Fund |
| Launch Date | Jun 05, 2004 |
| Benchmark | BSE Healthcare Index |
| Return Since Launch | 19.79% |
| Riskometer | Very High |
| Fund Category | Equity: Sectoral-Pharma |
| Expense Ratio | 1.78%(1.67% Category average) |
| Fund Size | Rs. 8,635.75 Cr(22.88% of Investment in Category) |
| Type | Open-ended |
| Risk Grade | Average |
| Return Grade | Below Average |
Nippon India Pharma Fund-Growth Investment Details
| Minimum Investment (Rs.) | 5,000.00 |
| Minimum Additional Investment (Rs.) | 1,000.00 |
| Minimum SIP Investment (Rs.) | 100.00 |
| Minimum Withdrawal (Rs.) | 100.00 |
| Exit Load Exit load of 1% if redeemed within 1 month. | |
Nippon India Pharma Fund-Growth Fund Key Highlights
1. Current NAV: The Current Net Asset Value of the Nippon India Pharma Fund as of Jun 17, 2026 is Rs 535.25 for Growth option of its Regular plan.
2. Returns: Its trailing returns over different time periods are: 4.65% (1yr), 22.18% (3yr), 12.32% (5yr) and 19.83% (since launch). Whereas, Category returns for the same time duration are: 9.63% (1yr), 23.51% (3yr) and 13.16% (5yr).
3. Fund Size: The Nippon India Pharma Fund currently holds Assets under Management worth of Rs 8635.75 crore as on May 31, 2026.
4. Expense ratio: The expense ratio of the fund is 1.78% for Regular plan as on Jun 12, 2026.
5. Exit Load: Nippon India Pharma Fund shall attract an Exit Load, "Exit load of 1% if redeemed within 1 month."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
1. Current NAV: The Current Net Asset Value of the Nippon India Pharma Fund as of Jun 17, 2026 is Rs 535.25 for Growth option of its Regular plan.
2. Returns: Its trailing returns over different time periods are: 4.65% (1yr), 22.18% (3yr), 12.32% (5yr) and 19.83% (since launch). Whereas, Category returns for the same time duration are: 9.63% (1yr), 23.51% (3yr) and 13.16% (5yr).
3. Fund Size: The Nippon India Pharma Fund currently holds Assets under Management worth of Rs 8635.75 crore as on May 31, 2026.
4. Expense ratio: The expense ratio of the fund is 1.78% for Regular plan as on Jun 12, 2026.
5. Exit Load: Nippon India Pharma Fund shall attract an Exit Load, "Exit load of 1% if redeemed within 1 month."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
Nippon India Pharma Fund-Growth Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns -1.78 7.01 5.57 5.52 20.43 12.64 Category Avg -0.32 10.07 8.04 10.10 21.83 13.43 Rank within Category 26 25 26 26 15 10 No. of funds within Category 33 33 30 27 17 12
Return Comparison
- BenchmarkS&P BSE Sensex
- Stock, MF & Index
Choose from Benchmarks
- Nifty 50
- NAV:--
- S&P BSE Sensex:--
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...
Portfolio Allocation
Asset Allocation
Loading...
Asset Allocation History
Loading...
EquityDebtCash
Sector Allocation
Loading...
Market Cap Allocation
Loading...
Concentration & Valuation Analysis
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 13.35 - - - Lupin Healthcare 7.31 - - - Dr. Reddy's Laboratories Healthcare 6.72 - - - Cipla Healthcare 6.16 - - - Divi's Laboratories Healthcare 5.8 - - - Apollo Hospitals Enterprise Healthcare 5.2 - - - Mankind Pharma Healthcare 3.94 - - - Medplus Health Services Healthcare 3.68 - - - Sai Life Sciences Healthcare 3.43 - - - Vijaya Diagnostic Centre Healthcare 3.21 - - -
Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y Nippon India Pharma Fund-Growth 535.25 8,635.75 -1.78 5.52 20.43 12.64 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth 41.36 6,453.52 -1.27 6.46 25.28 15.47 SBI Healthcare Opportunities Fund-Growth 468.57 4,565.95 1.58 9.38 23.45 15.57 UTI Healthcare Fund Regular Plan-Growth 312.34 1,216.85 2.08 11.01 24.94 14.29 Mirae Asset Healthcare Fund Regular - Growth 41.82 3,090.51 -0.92 11.60 23.07 14.03
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Standard Deviation
Low Volatality
15.78VS16.32Fund Vs Category Avg
Beta
Low Volatality
0.90VS0.93Fund Vs Category Avg
Sharpe Ratio
Poor risk-adjusted returns
1.00VS1.04Fund Vs Category Avg
Treynor's Ratio
Poor risk-adjusted returns
17.58VS18.24Fund Vs Category Avg
Jensen's Alpha
Poor risk-adjusted returns
-1.33VS-0.82Fund Vs Category Avg
Mean Return
Poor average monthly returns
21.71VS22.79Fund Vs Category Avg
Risk Ratio Chart
Loading...
- Risk Ratio
- Category Average
Size of Bubbles represents the Fund Size
Nippon India Mutual Fund News
- MF Tracker: Nippon India Value Fund turns Rs 10,000 SIP to Rs 1.56 crore in 21 years
- MF Tracker: Nippon India Value Find turns Rs 10,000 SIP to Rs 1.56 crore in 21 years
- Nippon India Mutual Fund limits subscription in Gold BeES and gold savings fund
- Paytm block deal: SocGen, Ghisallo, Viridian among biggest buyers in Rs 964 crore stake sale
Fund Manager
- S.S.Sanjeev SharmaSince Feb 2025
- A.A.Ankit A PandeSince May 2020
- S.T.Sandeep TandonSince Feb 2025
- V.P.Varun PattaniSince Feb 2025
- A.K.Ayusha KumbhatSince Feb 2025
Mr. Sharma is a Commerce Graduate and PGDBA (Finance) from Symbiosis, Pune. He has total work experience of 17 years including 13 years of experience in the financial market. He specializes in identifying crucial inflexion points in securities.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y Quant Dynamic Asset Allocation Fund Regular - Growth Dynamic Asset Allocation 16.47 922.29 0.06 Quant Multi Asset Allocation Fund Regular-Growth Multi Asset Allocation 166.96 5,615.03 18.92 Quant Gilt Fund Regular - Growth Gilt 12.04 79.59 1.43 Quant Value Fund Regular - Growth Value Oriented 22.39 1,859.34 17.07 Quant Infrastructure Fund-Growth Thematic-Infrastructure 41.20 3,193.89 9.92 Quant Overnight Fund Regular - Growth Overnight 12.40 113.64 5.08 Quant Large Cap Fund Regular - Growth Large Cap 15.54 3,281.16 5.59 Quant Liquid Fund-Growth Liquid 43.57 1,247.10 5.73 Quant Flexi Cap Fund-Growth Flexi Cap 106.83 6,993.58 10.98 Quant Arbitrage Fund Regular - Growth Arbitrage 10.82 Unrated 408.17 6.70 Quant PSU Fund Regular - Growth Thematic-PSU 10.75 Unrated 489.63 3.10 Quant Consumption Fund Regular - Growth Thematic-Consumption 10.00 Unrated 194.32 -1.00 Quant Commodities Fund Regular - Growth Thematic 14.79 Unrated 367.88 13.26 Quant Momentum Fund Regular - Growth Thematic 15.20 Unrated 1,359.93 6.04 Quant Teck Fund Regular - Growth Sectoral-Technology 10.87 Unrated 259.96 -15.85 Quant Manufacturing Fund Regular - Growth Thematic-Manufacturing 16.03 Unrated 709.90 10.15 Quant Healthcare Fund Regular - Growth Sectoral-Pharma 16.30 Unrated 372.50 5.56 Quant BFSI Fund Regular - Growth Sectoral-Banking 20.16 Unrated 783.90 18.93 Quant Business Cycle Fund Regular-Growth Thematic-Business Cycle 16.51 Unrated 1,017.72 3.73 Quant Quantamental Fund Regular - Growth Thematic-Quant 25.15 Unrated 1,644.61 11.58 Quant ESG Integration Strategy Fund Regular - Growth Thematic-ESG 37.88 Unrated 294.07 14.47 Mr. Pande has done CFA and MBA Prior to joining Quant Mutual Fund he has worked with Infosys Finacle. Began his career in equity research in 2011.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y Quant Dynamic Asset Allocation Fund Regular - Growth Dynamic Asset Allocation 16.47 922.29 0.06 Quant Multi Asset Allocation Fund Regular-Growth Multi Asset Allocation 166.96 5,615.03 18.92 Quant Small Cap Fund-Growth Small Cap 274.02 31,773.74 8.58 Quant Value Fund Regular - Growth Value Oriented 22.39 1,859.34 17.07 Quant Focused Fund-Growth Large Cap 90.73 840.38 6.50 Quant Aggressive Hybrid Fund Regular-Growth Aggressive Hybrid 459.87 2,127.82 10.15 Quant Large Cap Fund Regular - Growth Large Cap 15.54 3,281.16 5.59 Quant Large and Mid Cap Fund-Growth Large & MidCap 121.54 3,423.84 4.99 Quant Infrastructure Fund-Growth Thematic-Infrastructure 41.20 3,193.89 9.92 Quant Flexi Cap Fund-Growth Flexi Cap 106.83 6,993.58 10.98 Quant Mid Cap Fund-Growth Mid Cap 217.56 8,109.12 0.25 Quant Multi Cap Fund Regular-Growth Multi Cap 642.80 7,663.81 2.91 Quant PSU Fund Regular - Growth Thematic-PSU 10.75 Unrated 489.63 3.10 Quant Consumption Fund Regular - Growth Thematic-Consumption 10.00 Unrated 194.32 -1.00 Quant Commodities Fund Regular - Growth Thematic 14.79 Unrated 367.88 13.26 Quant Momentum Fund Regular - Growth Thematic 15.20 Unrated 1,359.93 6.04 Quant Teck Fund Regular - Growth Sectoral-Technology 10.87 Unrated 259.96 -15.85 Quant Manufacturing Fund Regular - Growth Thematic-Manufacturing 16.03 Unrated 709.90 10.15 Quant Healthcare Fund Regular - Growth Sectoral-Pharma 16.30 Unrated 372.50 5.56 Quant BFSI Fund Regular - Growth Sectoral-Banking 20.16 Unrated 783.90 18.93 Quant Business Cycle Fund Regular-Growth Thematic-Business Cycle 16.51 Unrated 1,017.72 3.73 Quant Quantamental Fund Regular - Growth Thematic-Quant 25.15 Unrated 1,644.61 11.58 Quant ESG Integration Strategy Fund Regular - Growth Thematic-ESG 37.88 Unrated 294.07 14.47 Mr. Tandon has done MBA (Finance) Prior to joining Quant Mutual Fund, he has worked with ICICI Securities as Vice President, The Economic Times and IDBI AMC.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y Quant Small Cap Fund-Growth Small Cap 274.02 31,773.74 8.58 Quant Focused Fund-Growth Large Cap 90.73 840.38 6.50 Quant Aggressive Hybrid Fund Regular-Growth Aggressive Hybrid 459.87 2,127.82 10.15 Quant Infrastructure Fund-Growth Thematic-Infrastructure 41.20 3,193.89 9.92 Quant Large and Mid Cap Fund-Growth Large & MidCap 121.54 3,423.84 4.99 Quant Mid Cap Fund-Growth Mid Cap 217.56 8,109.12 0.25 Quant Multi Cap Fund Regular-Growth Multi Cap 642.80 7,663.81 2.91 Quant ESG Integration Strategy Fund Regular - Growth Thematic-ESG 37.88 Unrated 294.07 14.47 Quant Consumption Fund Regular - Growth Thematic-Consumption 10.00 Unrated 194.32 -1.00 Quant PSU Fund Regular - Growth Thematic-PSU 10.75 Unrated 489.63 3.10 Quant Commodities Fund Regular - Growth Thematic 14.79 Unrated 367.88 13.26 Mr. Pattani is an ACA Prior to joining Quant Mutual Fund, he has worked with boutique PMS firm.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y Quant Dynamic Asset Allocation Fund Regular - Growth Dynamic Asset Allocation 16.47 922.29 0.06 Quant Multi Asset Allocation Fund Regular-Growth Multi Asset Allocation 166.96 5,615.03 18.92 Quant Small Cap Fund-Growth Small Cap 274.02 31,773.74 8.58 Quant Value Fund Regular - Growth Value Oriented 22.39 1,859.34 17.07 Quant Aggressive Hybrid Fund Regular-Growth Aggressive Hybrid 459.87 2,127.82 10.15 Quant Focused Fund-Growth Large Cap 90.73 840.38 6.50 Quant Large Cap Fund Regular - Growth Large Cap 15.54 3,281.16 5.59 Quant Infrastructure Fund-Growth Thematic-Infrastructure 41.20 3,193.89 9.92 Quant Flexi Cap Fund-Growth Flexi Cap 106.83 6,993.58 10.98 Quant Large and Mid Cap Fund-Growth Large & MidCap 121.54 3,423.84 4.99 Quant Mid Cap Fund-Growth Mid Cap 217.56 8,109.12 0.25 Quant Multi Cap Fund Regular-Growth Multi Cap 642.80 7,663.81 2.91 Quant ESG Integration Strategy Fund Regular - Growth Thematic-ESG 37.88 Unrated 294.07 14.47 Quant Quantamental Fund Regular - Growth Thematic-Quant 25.15 Unrated 1,644.61 11.58 Quant Business Cycle Fund Regular-Growth Thematic-Business Cycle 16.51 Unrated 1,017.72 3.73 Quant Momentum Fund Regular - Growth Thematic 15.20 Unrated 1,359.93 6.04 Quant Consumption Fund Regular - Growth Thematic-Consumption 10.00 Unrated 194.32 -1.00 Quant Teck Fund Regular - Growth Sectoral-Technology 10.87 Unrated 259.96 -15.85 Quant BFSI Fund Regular - Growth Sectoral-Banking 20.16 Unrated 783.90 18.93 Quant Manufacturing Fund Regular - Growth Thematic-Manufacturing 16.03 Unrated 709.90 10.15 Quant Commodities Fund Regular - Growth Thematic 14.79 Unrated 367.88 13.26 Quant PSU Fund Regular - Growth Thematic-PSU 10.75 Unrated 489.63 3.10 Quant Healthcare Fund Regular - Growth Sectoral-Pharma 16.30 Unrated 372.50 5.56 CFA Level III, BSc (Hons) in Economics, MSc in Behavioural & Experimental Economics She is working with Quant Mutual fund as Research Analyst for the past 15 months, specializing in investment research.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y Quant Dynamic Asset Allocation Fund Regular - Growth Dynamic Asset Allocation 16.47 922.29 0.06 Quant Multi Asset Allocation Fund Regular-Growth Multi Asset Allocation 166.96 5,615.03 18.92 Quant Aggressive Hybrid Fund Regular-Growth Aggressive Hybrid 459.87 2,127.82 10.15 Quant Focused Fund-Growth Large Cap 90.73 840.38 6.50 Quant Value Fund Regular - Growth Value Oriented 22.39 1,859.34 17.07 Quant Large Cap Fund Regular - Growth Large Cap 15.54 3,281.16 5.59 Quant Large and Mid Cap Fund-Growth Large & MidCap 121.54 3,423.84 4.99 Quant Mid Cap Fund-Growth Mid Cap 217.56 8,109.12 0.25 Quant Infrastructure Fund-Growth Thematic-Infrastructure 41.20 3,193.89 9.92 Quant Flexi Cap Fund-Growth Flexi Cap 106.83 6,993.58 10.98 Quant Multi Cap Fund Regular-Growth Multi Cap 642.80 7,663.81 2.91 Quant Quantamental Fund Regular - Growth Thematic-Quant 25.15 Unrated 1,644.61 11.58 Quant Business Cycle Fund Regular-Growth Thematic-Business Cycle 16.51 Unrated 1,017.72 3.73 Quant Commodities Fund Regular - Growth Thematic 14.79 Unrated 367.88 13.26 Quant PSU Fund Regular - Growth Thematic-PSU 10.75 Unrated 489.63 3.10 Quant Momentum Fund Regular - Growth Thematic 15.20 Unrated 1,359.93 6.04 Quant Healthcare Fund Regular - Growth Sectoral-Pharma 16.30 Unrated 372.50 5.56 Quant Manufacturing Fund Regular - Growth Thematic-Manufacturing 16.03 Unrated 709.90 10.15 Quant BFSI Fund Regular - Growth Sectoral-Banking 20.16 Unrated 783.90 18.93 Quant ESG Integration Strategy Fund Regular - Growth Thematic-ESG 37.88 Unrated 294.07 14.47 Quant Consumption Fund Regular - Growth Thematic-Consumption 10.00 Unrated 194.32 -1.00 Quant Teck Fund Regular - Growth Sectoral-Technology 10.87 Unrated 259.96 -15.85
More Nippon India Mutual Fund
| Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund - Growth | 74,604.07 | 2.85 | 16.06 | 7.13 | 4.81 | 18.10 | |
| Nippon India ETF Gold BeES | 56,755.04 | -4.79 | -2.88 | 13.50 | 49.87 | 34.58 | |
| Nippon India Multi Cap Fund-Growth | 53,410.99 | 1.69 | 7.60 | -0.05 | 0.62 | 17.01 | |
| Nippon India Large Cap Fund-Growth | 51,660.30 | 1.97 | 4.03 | -4.66 | -0.88 | 13.64 | |
| Nippon India Growth Mid Cap Fund - Growth | 47,415.41 | 2.20 | 11.22 | 6.15 | 7.43 | 22.26 | |
| Nippon India Silver ETF - Growth | 32,936.55 | -6.99 | 1.67 | 28.87 | 129.64 | 48.94 | |
| Nippon India Liquid Fund-Growth | 31,752.32 | 0.62 | 1.83 | 3.27 | 6.21 | 6.87 | |
| Nippon India Liquid Fund Retail-Growth | 31,752.32 | 0.61 | 2.34 | 3.63 | 6.26 | 6.48 | |
| Nippon India Money Market Fund-Growth | 21,262.69 | 0.69 | 1.69 | 2.94 | 6.03 | 7.22 | |
| CPSE ETF-Growth | 20,959.27 | -7.99 | -3.75 | 9.92 | 3.75 | 30.69 |
Mutual Fund Tools
Top AMCs
Fund For AMC data not available for this fund
FAQs about Nippon India Pharma Fund-Growth
- Is it safe to invest in Nippon India Pharma Fund?As per SEBI’s latest guidelines to calculate risk grades, investment in the Nippon India Pharma Fund comes under Very High risk category.
- What is the category of Nippon India Pharma Fund?Nippon India Pharma Fund belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in Nippon India Pharma Fund?The suggested investment horizon of investing into Nippon India Pharma Fund is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the Nippon India Pharma Fund?The Nippon India Pharma Fund is managed by Sailesh Raj Bhan (Since Mar 01, 2005) and Amber Singhania (Since Mar 11, 2026).
About Nippon India Pharma Fund-Growth
1. Nippon India Pharma Fund is Open-ended Sectoral-Pharma Equity scheme which belongs to Nippon India Mutual Fund House.
2. The fund was launched on Jun 05, 2004.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. "
2. It is benchmarked against BSE Healthcare Index.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 97.98% in equities, 0.0% in debts and 2.02% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 58.8% of the assets, the top 3 sectors constitute around 97.98% of the assets.
3. The fund largely follows a Growth oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on Nippon India Pharma Fund-Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
1. Nippon India Pharma Fund is Open-ended Sectoral-Pharma Equity scheme which belongs to Nippon India Mutual Fund House.
2. The fund was launched on Jun 05, 2004.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. "
2. It is benchmarked against BSE Healthcare Index.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 97.98% in equities, 0.0% in debts and 2.02% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 58.8% of the assets, the top 3 sectors constitute around 97.98% of the assets.
3. The fund largely follows a Growth oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on Nippon India Pharma Fund-Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.